First human test for new hives drug begins
NCT ID NCT06604949
Summary
This is a very early, first-in-human study to check the safety and basic effects of a single dose of a new drug called LP-003. It involves 12 healthy adults and will measure how their bodies react to and process the drug. The goal is to gather initial safety data to see if LP-003 can be studied further as a potential treatment for chronic hives (urticaria).
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC SPONTANEOUS URTICARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai General Hospital
Shanghai, China
Conditions
Explore the condition pages connected to this study.